A family of localized immunotherapies.

Pipeline

One day, all solid cancers will be managed with dose-unlimited, localized immunotherapy.

Starting with breast and head & neck cancers, built for every solid tumor.

XCSgel can be paired with different immunotherapies and injected into tumors throughout the body. Our lead program, IT-001, targets triple-negative breast cancer and head and neck cancers.

Veterinary Studies

Treating pets with naturally-occurring cancers

Cancers that arise naturally in dogs and horses closely resemble human disease. In collaboration with the NC State College of Veterinary Medicine, these studies help pets and generate data to guide clinical development.

Canine

Soft-tissue sarcoma

IT-001 is being evaluated in pet dogs with soft-tissue sarcoma, including whether it can enhance the effect of radiation therapy.

Canine

Melanoma

Assessing whether IT-001 can strengthen irreversible electroporation, a minimally invasive tumor ablation technique, in dogs with melanoma.

Equine

Melanoma

Evaluating IT-001 in horses with melanoma, a common cancer in gray horses that often forms multiple injectable tumors.